ORIENTTECH’s topline growth hinges on annuity mix execution (NOC/SOC, government contracts) and hardware recovery timing; bottom-line leverage requires margin normalization post-FY26 contract resets, with AI tailwinds as upside optionalities.
📊 Base Case (50% Probability)
Key Variables: Supply chain normalizes by late FY27; NOC/SOC hits 70% utilization by FY28.
Outcome: Revenue grows 12–15% CAGR to ₹850–900 crore FY27, with EBITDA margins recovering to 7–9% on services mix improvement. EPS ₹2.50–3.00 as government/pharma contracts scale.
MUTHOOTFIN: Gold loan structural tailwinds and regulatory support underpin 18–22% AUM growth, but earnings quality hinges on NPA recovery sustainability and opex discipline; margins face 50–100 bps compression if cost inflation outpaces revenue, while competitive and macro risks cap upside to low-teens EPS growth.
📊 Base Case (50% Probability)
Key Variables: Gold prices stable (±5%), MCLR pass-through in H2, regulated branch growth.
Outcome: AUM grows 18–22%, NIM stable at ~7.5% (recoveries offset funding lag). Opex growth moderates to 15%, margins 26–28%. EPS grows 8–12%, driven by gold loan dominance and subsidiary turnarounds. Guidance clarity supports valuation rerating.